INOVA is proud of our scientific prowess which is made evident by our numerous publications in peer reviewed scientfic journals. Please feel free to review the references below which are arranged by disease state.
Liver |Antiphospholipid Syndrome | Connective Tissue | Gastrointestinal | RA
Papp, M, Altorjay I, Norman, GL, Shums, Z, Palatka, K, Vitalis Z, Foldi I, Lakos, G, Tumpek, J, Udvasrdy ML, Harsfalvi J, Fischer S, Lakatos L, Kovacs A, Bene L, Molnar R, Tulassay Z, Miheller P, Veres G, Papp J, Lakatos PL. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/Card15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflamm Bowel Dis. 2007 Apr 6. Crohn's & Colitis Foundation of America copyright 2007.
Papp, Maria, Norman, GL, Altorjay, I, Lakatos,P.L. Utility of serological markers in inflammatory bowel diseases: Gadget or magic? World J Gastroenterol 2007 April 14; 13(14): 2028-2036.
Ferrante, M, Henckaerts,L, Joossens, M, Pierik,M. Joossens, S, Dotan,N, Norman, GL, Altstock, R, Van Steen,K, Rugeerts, P, Van Assche,G, and Vermeire,S. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut. Published online first: 24 April 2007.
Czaja, AJ, Shums, Z, Norman GL. Nonstandard Antibodies as Prognostic Markers in Autoimmune Hepatitis. Autoimmunity 2004. 37(3): 195-201. American Gastrological Assn. Annual Meeting (DDW) 2004.
Czaja, A.J., Shums, Z., Donaldson, P.T., Norman, GL. Frequency and Significance of Antibodies to Saccharomyces cerevisiae in Autoimmune Hepatitis. Dig.Dis.Sci. 2004; Vol 49(4) 611-618.
Harrer, M, Reinisch, W, Dejaco, C, Kratzer, V., Gmeiner, M, Miehsler, W, Norman, GL, Gangl, A, Vogelsand, H. Do high Serum Levels of Anti-Saccharomyces cerevisiae antibodies (ASCA) result from a Leakyness of the Gut Barrier in Crohn's Disease? European J. Gastroenterology and Hepatalogy. 2003 Dec; 15(12): 1281-5.
Teml, A., Kratzer, V., Schneider, B., Lochs, H., Norman, GL, Gangi, A., Vogelsang, H., Reinisch, W. Anti-Saccharomyces cerevisiae antibodies: A stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment. Amer. J. Gastroenterology. 2003, 98(10): 2226-2231.
Prince, H.E., Norman, G.L., and Binder, W.L. Immunoglobulin A (IgA) deficiency and alternative celiac disease-associated antibodies in sera submitted to a reference laboratory for endomysial IgA testing. Clinical and Diagnostic Immunology. 2000.
Beutner, EH, Baughman, RD, Austin, BM, Plunkett, RW, and Binder, WL. A case of dermatitis herpetiformis with IgA endomysial antibodies but negative direct immunofluorescent findings. Copyright August 2000 by the American Academy of Dermatology Inc. 329-332. J. Am. Acad. Vol 43, No 2 part 2.
Norman, G.L. Anti-Saccharomyces cerevisiae Antibodies in Inflammatory Bowel Disease. Clinical and Applied Immunology Reviews 2: 45-63, 2001.
Norman, GL, Gandhi, Z, Crowther, T, Binder, WL, Kratzer, V, Reinisch, W, and Vogelsang, H. IgG and IgA Anti-Saccharomyces cereivisiae Atibodies (ASCA) Detection by ELISA in Crohn's Disease. Ulcerative colitis, and Healthy Patient Groups., Gastoenterol. 2000; 118(4, suppl 2): A105. American Gastrological Association 2000 Annual Meeting, San Diego, CA May 2000.
Norman, GL, Gandhi, Z, Crowther, T, Binder, WL. A Cytochrome P4502D6 ELISA for Detection of Liver-Kidney Microsomal (LKM-1) Antibodies in Patients and Healthy Patient Groups. Gastroenterol. 2000; 118(4, supl 2): A897. American Association for the Study of Liver Diseases/Digestive Disease Week Meeting (selected as "DDW Poster of Distinction") San Diego, May 2000.